Celularity Historical Balance Sheet

CELU Stock

USD 1.82 0.09 5.20%

Trend analysis of Celularity balance sheet accounts such as Short Long Term Debt Total of 40.5 M, Other Current Liabilities of 8.9 M or Total Current Liabilities of 39.3 M provides information on Celularity's total assets, liabilities, and equity, which is the actual value of Celularity to its prevalent stockholders. By breaking down trends over time using Celularity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Celularity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Celularity is a good buy for the upcoming year.

Celularity Inventory

5.81 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

About Celularity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Celularity at a specified time, usually calculated after every quarter, six months, or one year. Celularity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Celularity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Celularity currently owns. An asset can also be divided into two categories, current and non-current.

Celularity Balance Sheet Chart

At this time, Celularity's Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Net Invested Capital is likely to gain to about 96.8 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 39.3 M in 2025.

Short Long Term Debt Total Net Tangible Assets Cash Cash And Short Term Investments Other Current Assets

Add Fundamental

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Cash

Cash refers to the most liquid asset of Celularity, which is listed under current asset account on Celularity balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Celularity customers. The amounts must be unrestricted with restricted cash listed in a different Celularity account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Celularity balance sheet. This account contains Celularity investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Celularity fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from Celularity's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.At this time, Celularity's Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Net Invested Capital is likely to gain to about 96.8 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 39.3 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	65.6M	65.4M	75.2M	40.5M
Total Assets	401.1M	143.9M	165.5M	286.9M

Short Long Term Debt Total Total Assets

Celularity balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Warrants
Total Assets		0.68	0.81	0.57	-0.06	-0.42	0.78	0.31	-0.73	0.23	0.74	1.0	-0.14	0.89	0.74	0.4	0.88	0.6	0.7	0.6	0.71	0.86	0.24	0.87	0.84	-0.76
Short Long Term Debt Total	0.68		0.66	0.97	0.18	-0.87	0.82	0.77	-0.9	0.76	0.23	0.68	0.04	0.89	0.23	0.89	0.91	0.63	0.52	0.94	0.32	0.6	0.07	0.93	0.81	-0.89
Other Current Liab	0.81	0.66		0.68	-0.35	-0.5	0.91	0.27	-0.78	0.36	0.75	0.77	0.39	0.69	0.75	0.59	0.69	0.59	0.85	0.57	0.77	0.93	-0.3	0.76	0.92	-0.84
Total Current Liabilities	0.57	0.97	0.68		0.09	-0.91	0.84	0.75	-0.92	0.83	0.2	0.55	0.28	0.77	0.2	0.95	0.8	0.65	0.51	0.92	0.3	0.59	-0.18	0.86	0.82	-0.91
Total Stockholder Equity	-0.06	0.18	-0.35	0.09		-0.35	-0.33	0.52	0.05	0.09	-0.59	0.0	-0.4	0.04	-0.59	-0.05	0.07	0.21	-0.4	0.37	-0.73	-0.52	0.41	0.02	-0.15	0.1
Other Liab	-0.42	-0.87	-0.5	-0.91	-0.35		-0.67	-0.91	0.84	-0.78	0.1	-0.42	-0.27	-0.62	0.09	-0.85	-0.64	-0.62	-0.33	-0.89	0.02	-0.35	0.18	-0.69	-0.7	0.81
Net Tangible Assets	0.78	0.82	0.91	0.84	-0.33	-0.67		0.43	-0.94	0.61	0.63	0.75	0.36	0.81	0.63	0.8	0.81	0.64	0.73	0.71	0.72	0.92	-0.26	0.88	0.95	-0.96
Net Debt	0.31	0.77	0.27	0.75	0.52	-0.91	0.43		-0.63	0.62	-0.34	0.33	-0.06	0.56	-0.34	0.7	0.56	0.38	0.22	0.75	-0.22	0.12	0.13	0.56	0.5	-0.61
Retained Earnings	-0.73	-0.9	-0.78	-0.92	0.05	0.84	-0.94	-0.63		-0.77	-0.42	-0.71	-0.31	-0.83	-0.42	-0.87	-0.84	-0.78	-0.53	-0.87	-0.48	-0.76	0.2	-0.9	-0.94	0.99
Accounts Payable	0.23	0.76	0.36	0.83	0.09	-0.78	0.61	0.62	-0.77		-0.01	0.21	0.33	0.55	-0.01	0.92	0.59	0.68	0.02	0.81	0.06	0.32	-0.24	0.64	0.61	-0.74
Cash	0.74	0.23	0.75	0.2	-0.59	0.1	0.63	-0.34	-0.42	-0.01		0.7	0.15	0.51	1.0	0.12	0.5	0.4	0.62	0.15	0.94	0.87	-0.1	0.52	0.61	-0.47
Non Current Assets Total	1.0	0.68	0.77	0.55	0.0	-0.42	0.75	0.33	-0.71	0.21	0.7		-0.19	0.89	0.7	0.38	0.88	0.6	0.67	0.61	0.67	0.82	0.29	0.87	0.81	-0.74
Non Currrent Assets Other	-0.14	0.04	0.39	0.28	-0.4	-0.27	0.36	-0.06	-0.31	0.33	0.15	-0.19		-0.22	0.15	0.33	-0.19	0.3	0.18	0.11	0.15	0.25	-0.99	-0.05	0.31	-0.31
Other Assets	0.89	0.89	0.69	0.77	0.04	-0.62	0.81	0.56	-0.83	0.55	0.51	0.89	-0.22		0.51	0.69	0.99	0.62	0.56	0.79	0.56	0.75	0.33	0.98	0.84	-0.85
Cash And Short Term Investments	0.74	0.23	0.75	0.2	-0.59	0.09	0.63	-0.34	-0.42	-0.01	1.0	0.7	0.15	0.51		0.12	0.5	0.4	0.62	0.15	0.94	0.87	-0.1	0.53	0.61	-0.47
Net Receivables	0.4	0.89	0.59	0.95	-0.05	-0.85	0.8	0.7	-0.87	0.92	0.12	0.38	0.33	0.69	0.12		0.71	0.57	0.38	0.83	0.27	0.53	-0.24	0.77	0.75	-0.86
Common Stock Total Equity	0.88	0.91	0.69	0.8	0.07	-0.64	0.81	0.56	-0.84	0.59	0.5	0.88	-0.19	0.99	0.5	0.71		0.65	0.54	0.83	0.54	0.74	0.3	0.99	0.83	-0.85
Inventory	0.6	0.63	0.59	0.65	0.21	-0.62	0.64	0.38	-0.78	0.68	0.4	0.6	0.3	0.62	0.4	0.57	0.65		0.12	0.81	0.24	0.52	-0.2	0.71	0.77	-0.76
Other Current Assets	0.7	0.52	0.85	0.51	-0.4	-0.33	0.73	0.22	-0.53	0.02	0.62	0.67	0.18	0.56	0.62	0.38	0.54	0.12		0.29	0.75	0.81	-0.13	0.57	0.67	-0.59
Other Stockholder Equity	0.6	0.94	0.57	0.92	0.37	-0.89	0.71	0.75	-0.87	0.81	0.15	0.61	0.11	0.79	0.15	0.83	0.83	0.81	0.29		0.14	0.46	-0.01	0.86	0.77	-0.85
Total Liab	0.71	0.32	0.77	0.3	-0.73	0.02	0.72	-0.22	-0.48	0.06	0.94	0.67	0.15	0.56	0.94	0.27	0.54	0.24	0.75	0.14		0.92	-0.09	0.57	0.63	-0.53
Total Current Assets	0.86	0.6	0.93	0.59	-0.52	-0.35	0.92	0.12	-0.76	0.32	0.87	0.82	0.25	0.75	0.87	0.53	0.74	0.52	0.81	0.46	0.92		-0.16	0.79	0.88	-0.81
Common Stock	0.24	0.07	-0.3	-0.18	0.41	0.18	-0.26	0.13	0.2	-0.24	-0.1	0.29	-0.99	0.33	-0.1	-0.24	0.3	-0.2	-0.13	-0.01	-0.09	-0.16		0.17	-0.19	0.2
Property Plant Equipment	0.87	0.93	0.76	0.86	0.02	-0.69	0.88	0.56	-0.9	0.64	0.52	0.87	-0.05	0.98	0.53	0.77	0.99	0.71	0.57	0.86	0.57	0.79	0.17		0.89	-0.91
Property Plant And Equipment Net	0.84	0.81	0.92	0.82	-0.15	-0.7	0.95	0.5	-0.94	0.61	0.61	0.81	0.31	0.84	0.61	0.75	0.83	0.77	0.67	0.77	0.63	0.88	-0.19	0.89		-0.97
Warrants	-0.76	-0.89	-0.84	-0.91	0.1	0.81	-0.96	-0.61	0.99	-0.74	-0.47	-0.74	-0.31	-0.85	-0.47	-0.86	-0.85	-0.76	-0.59	-0.85	-0.53	-0.81	0.2	-0.91	-0.97

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	431.0M	414.1M	401.1M	143.9M	165.5M	286.9M
Short Long Term Debt Total	30.6M	31.1M	65.6M	65.4M	75.2M	40.5M
Other Current Liab	18.3M	11.7M	16.4M	2.4M	11.1M	8.9M
Total Current Liabilities	26.7M	26.2M	62.1M	67.3M	77.4M	39.3M
Total Stockholder Equity	(531.4M)	99.4M	198.9M	41.0M	47.1M	49.5M
Other Liab	334.9M	358.0M	260.4M	112.1M	100.9M	95.8M
Net Tangible Assets	(726.0M)	214.1M	(147.1M)	(41.8M)	(48.1M)	(50.5M)
Net Debt	(23.7M)	(6.1M)	51.6M	39.0M	65.2M	68.4M
Retained Earnings	(563.6M)	(663.7M)	(645.5M)	(841.8M)	(757.6M)	(795.5M)
Accounts Payable	5.4M	9.3M	5.8M	14.1M	16.3M	9.1M
Cash	54.3M	37.2M	14.0M	227K	204.3K	194.1K
Non Current Assets Total	358.8M	376.9M	367.6M	124.1M	142.7M	258.1M
Non Currrent Assets Other	20.1M	39.8M	23.3M	26.9M	31.0M	32.5M
Cash And Short Term Investments	54.3M	37.2M	14.0M	227K	261.1K	248.0K
Net Receivables	6.6M	5.2M	7.0M	10.0M	12.1M	7.5M
Liabilities And Stockholders Equity	431.0M	414.1M	401.1M	143.9M	165.5M	308.3M
Inventory	3.9M	9.5M	5.3M	5.8M	6.6M	5.8M
Other Current Assets	7.4M	2K	7.3M	329K	1.7M	2.7M
Other Stockholder Equity	32.2M	763.1M	844.4M	882.7M	1.0B	510.0M
Total Liab	962.4M	314.7M	202.2M	102.9M	92.6M	88.0M
Total Current Assets	72.2M	37.2M	33.5M	19.8M	22.8M	28.8M
Common Stock	1K	12K	15K	19K	17.1K	16.2K
Property Plant And Equipment Net	90.1M	90.6M	88.7M	78.8M	90.6M	90.5M
Common Stock Shares Outstanding	9.2M	6.7M	15.0M	19.4M	17.8M	13.1M
Non Current Liabilities Total	935.7M	288.5M	140.1M	35.6M	32.1M	30.5M
Non Current Liabilities Other	74.6M	232.6M	106.3M	1.9M	2.2M	2.1M
Intangible Assets	125.4M	123.2M	121.0M	11.0M	9.9M	9.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Historical Balance Sheet

Celularity Inventory

5.81 Million

About Celularity Balance Sheet Analysis

Celularity Balance Sheet Chart

Net Tangible Assets

Cash

Cash And Short Term Investments

Other Current Assets

Celularity balance sheet Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Celularity balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Warrants	+ 0.99	Retained Earnings
Common Stock Total Equity	+ 0.99	Other Assets
Property Plant Equipment	+ 0.99	Common Stock Total Equity
Property Plant Equipment	+ 0.98	Other Assets

Common Stock	- 0.99	Non Currrent Assets Other
Warrants	- 0.97	Property Plant And Equipment Net
Warrants	- 0.96	Net Tangible Assets
Property Plant And Equipment Net	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Net Tangible Assets
Retained Earnings	- 0.92	Total Current Liabilities